Searched for
SANOFI PASTEUR INDIA
Polio vaccine shortage looms over India with Sanofi plants' shutdownAn impending crisis looms over India's supply of injectable poliomyelitis vaccine (IPV) as French drugmaker Sanofi has shut down its manufa...
Sanofi, GSK receive nod for Phase 3 trial of COVID-19 vaccine candidate in IndiaThe design of the Phase 3 study, conducted across a broad diversity of geographies, also allows evaluation of the efficacy of the candidate...
Shared latest data on dengue vaccine with authorities: SanofiYesterday, the Philippines government ordered an investigation into the immunisation of more than 7.3 lakh children with the company's deng...
Shantha Biotechnics begins commercial production at new unitThe new facility, located in SEZ Muppireddipalli near Hyderabad, has the latest technology to produce vaccines that meet global standards o...
Government may exempt Sanofi’s dengue vaccine from large-scale clinical trialsIf cleared, the step may eventually pave the way for Dengvaxia's availability via the wide government distribution system and private chann...
World's first dengue vaccine gets nod after 20 years of researchThe injection can thwart all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently, according to WHO.
Sanofi Pasteur launches injectable inactivated polio vaccineSanofi Pasteur, the vaccines division of Sanofi, today announced launch of ShanIPV, an injectable inactivated polio vaccine (IPV).
Glaxo considering all options against CCI orderSlapped with a penalty of nearly Rs 61 crore by competition watchdog CCI, GlaxoSmithKline Pharmaceuticals today said it would review the or...
Sanofi launches Shan5 paediatric pentavalent vaccineShantha, a fully integrated biotechnology company involved in R and D, manufacturing and marketing, was acquired by Sanofi Pasteur Holding ...
Sanofi Pasteur launches Shan5 paediatric pentavalent vaccineShantha, a fully integrated biotechnology company involved in R and D, manufacturing and marketing, was acquired by Sanofi Pasteur Holding ...
World's 1st dengue vaccine likely by 2015: SanofiCountry Head, Sanofi Pasteur, Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported bur...
Sanofi unit starts Phase 3 clinical trial of rotavirus vaccineIndia has the largest disease burden for rotavirus gastroenteritis in the world, according to Shantha Chief Executive Harish Iyer.
Taxman summons Shanta Biotech top brass on Sanofi deal; Sanofi may challenge retro tax lawsIncome tax authorities summoned the management of Hyderabad based Shanta Biotechnics in connection with an outstanding tax demand of Rs 105...
- Sanofi seeks French help on possible tax on Shantha deal
The transaction that took place between the sellers and Sanofi Pasteur in 2009 for the acquisition of the French company ShanH was subject ...
- Sanofi ropes in Raveena Tandon for campaign against flu
Sanofi Pasteur has roped in Bollywood actor for its 'Mothers Against Flu' campaign, an initiative on Facebook to create awareness on the pr...
- Sanofi expects 50 pc Indian market share for flu vaccines
The co today launched 'Mothers Against Flu', a facebook community of mothers. The company has roped in actress Raveena Tandon for the campa...
- Our aim is to bring affordable vaccines to different regions: Harish Iyer, Shantha Biotech
Barely two months into his new job after walking away as Biocon’s research head, Iyer echoes the language of a seasoned vaccine maker.
- Merck plans to shift India head office to Mumbai
US-based drugmaker Merck plans to relocate headquarter of its India office to Mumbai, making it the third major pharma company to shift key...
- Sanofi-Aventis buys Shantha for Rs 3,740 cr
The deal between Sanofi its French owners Meriuex Alliance values the unlisted Indian company at Rs 3,740 crore, or about eight times its p...
- Sanofi arm may make India global output hub for vaccines
India may be a possible location as a global manufacturing base for vaccines business of Sanofi-Aventis Group.